EMOGLOBIN appears to play an important role in the pathogenesis of vasospasm after SAH. Modification of the metabolism of hemoglobin and heme may be important in the prevention of vasospasm. Oxidation of the ferrous iron in oxy-or deoxyhemoglobin produces methemoglobin, which more readily releases its heme groups from the globin chains. 5 Globin chains are probably degraded by intra-and extracellular proteases. The heme group is metabolized into biliverdin, CO, and iron by HOs that consist of at least three isozymes: the oxidative stressinducible protein HO-1, constitutively expressed HO-2, and HO-3.
tutional Animal Care and Use Committee. Male Sprague-Dawley rats weighing 250 to 300 g were used to examine the efficiency, location, and function of viral transgene expression in the subarachnoid space and BA. Methods for cisterna magna injection and creation of a cranial window have been described. 38 Briefly, purified adenovirus (0.1 ml of Ad5HO-1 or Ad-␤Gal containing 10 10 pfu) or 0.1 ml of 10% glycerol in saline (vehicle) were injected under sterile conditions into the cisterna magna of anesthetized rats. One day after the injection, rats were reanesthetized and placed supine in a stereotactic frame. The BA was exposed transclivally and its diameter was monitored using a surgical microscope equipped with a charge-coupled device camera, video monitor, and calibrated optical measuring device. Body temperature, blood pressure, and PaO 2 and PaCO 2 were measured using a rectal thermometer and a catheter inserted into the femoral artery, respectively, and values were maintained in the physiological range. The BA diameter was measured at baseline and after application of pure human ferrous hemoglobin A 0 in physiological phosphate buffer. Applications were made so that the final concentration in the window was 10 Ϫ7 to 10 Ϫ4 mol/L oxyhemoglobin, based on a volume of the rat subarachnoid space of 0.3 ml. 38 Brainstem blood flow was measured using laser Doppler flowmetry 1 mm lateral to the BA.
Assessment of Transgene Expression
The HO-1 mRNA was measured using RT-PCR 1 day after injection of Ad5HO-1, Ad-␤Gal, or vehicle into the cisterna magna. One day after virus injections, the rats were anesthetized and decapitated. The BAs were removed and placed in liquid N 2 . The RNA was extracted and amplified using methods described previous ly. 29 Sequences of HO-1 and ␤-actin (internal control) primers were 5Ј-AGAACCCAGTCTATGCCCCG-3Ј (sense primer), and 5Ј-TTGTCGATGCTCGGGAAGGTG-3Ј (antisense primer), 5Ј-AGA-TCATGTTTGAGACCTTCAACA-3Ј (sense primer) and 5Ј-GCA-CAGCTTCTCCTTAATGTC-3Ј (antisense primer), respectively. The PCRs were performed in triplicate and radioactivity was determined directly by using commercially available software.
Translation of viral transgene products into protein was assessed by immunoblotting of protein extracted from BAs used for PCR. This was compared with a positive control obtained by incubation of cultured rat BA smooth-muscle cells with 10 Ϫ6 mol/L pure hemoglobin. 29 Immunoblotting was performed according to previously published methods by using rabbit polyclonal antibody against rat HO-1. Signal detection was performed with an enhanced chemiluminescence detection kit. Quantification of the density of specific bands of HO-1 and internal standards was done using the National Institutes of Health Gel scan program and standardized as density per microgram protein measured using a protein assay.
For immunohistochemical localization of transgene expression, BAs from rats injected with Ad5HO-1, Ad-␤Gal, or vehicle were harvested 1 day postinjection, after transcardiac perfusion of the animals at physiological pressure with PBS, followed by 4% paraformaldehyde in PBS. Cross-sections of the brainstem were immersed in a graded series of sucrose solutions (up to 30%) and frozen sections were cut on a cryostat. Immunohistochemical studies were performed according to methods described previously, by using the same HO-1 antibody as for immunoblotting. 37, 42 Alternate control sections were incubated without primary antibody or with primary antibody alone. Slides were counterstained with hematoxylin.
Assay of HO Activity and Measurement of Carboxyhemoglobin
To determine whether viral transfections altered HO activity, assays were performed in transfected BAs. 33 The BAs were harvested 1 day after cisternal injection of Ad5HO-1, Ad-␤Gal, or vehicle, or in normal control rats after transcardiac perfusion of the animals at physiological blood pressure with PBS containing (in mM): 137 NaCl; 8.1 Na 2 HPO 4 ; 2.7 KCl; and 1.5 KH 2 PO 4 ; pH 7.4. The BAs were ground in a Dounce homogenizer in PBS and then assayed for HO activity by using a previously described spectrophotometric assay. 33 To further assess HO function, a semiquantitative calculation of the concentration of carboxyhemoglobin as a product of CO reaction with hemoglobin was determined in additional experiments in which hemoglobin was applied to the BA of untreated rats or after cisternal injection of vehicle, Ad5HO-1, or Ad-␤Gal. The CO content in the rat CSF was measured using spectrophotometry of hemoglobin and carboxyhemoglobin, according to established methods. 43 Pure human ferrous hemoglobin A 0 (final concentration 1 mmol/L) was applied to the BA, which was exposed through a cranial window as described earlier. The CSF was aspirated from the window after 30 minutes and the concentration of carboxyhemoglobin was measured as absorbance at 421 nm minus absorbance at the isobestic point (480 nm). The established extinction coefficient of 58.7 mmol/ L/cm was used to calculate the concentration of carboxyhemoglobin in CSF.
Experimental Model of SAH
A rat double-hemorrhage model of SAH was used to assess whether adenovirus-mediated HO-1 gene transfection prevents vasospasm in vivo. 48 Male Sprague-Dawley rats were randomly assigned to three groups to receive intracisternal Ad5HO-1, Ad-␤Gal, or vehicle. The investigator performing injections and analyzing data did so in a blinded fashion. On Day 0, animals were anesthetized and allowed to breathe spontaneously, after which 0.25 ml of arterial blood was mixed with 0.1 ml of Ad5HO-1, Ad-␤Gal (10 10 pfu), or vehicle and injected into the cisterna magna over 5 minutes. Rats were reanesthetized 2 days after the initial injection (Day 2) and given a seond injection of 0.3 ml of autologous arterial blood. Seven days after the first injection, rats were killed with overdoses of anesthetic agents and their tissues were harvested, or the animals were fixed by perfusion with PBS, followed by 4% paraformaldehyde in PBS at physiological blood pressure. Frozen sections of BA and brainstem were cut 10 m thick on the cryostat, and BA diameters were measured using a light microscope equipped with a micrometer. Crosssections of BA were obtained for measurement at three points: 200 m above the union of the vertebral arteries, just below the anterior inferior cerebellar arteries, and 200 m below the BA bifurcation. The mean of the three points was used as the diameter of the BA.
Data Analysis
All data analysis was conducted in a blinded fashion, and data are expressed as the mean Ϯ standard deviation. Comparisons of levels of mRNA and protein, and arterial diameter and blood flow within and between groups, were made using ANOVA for multiple comparisons, followed by pairwise comparisons with the Fisher test if significant variance was found. Paired or unpaired t-tests were used for comparisons between two measurements. A probability value of less than 0.05 was considered statistically significant.
Sources of Supplies and Equipment
The charge-coupled device camera and video monitor were purchased from Hitachi, Yokohama, Japan. The optical measuring device and the micrometer-equipped light microscope were acquired from Fisher Scientific, Pittsburgh, PA. The blood pressure monitoring device was obtained from Stoelting, Wood Dale, IL, and the PaO 2 and PaCO 2 monitoring device (i-STAT System) was obtained from Sensor Devices, Waukesha, WI. The purified hemoglobin was supplied by Hemosol, Etobicoke, ON. The LDF device was purchased from Transonic Systems, Ithaca, NY. The Phosphor Imager and Image Quant software were acquired from Molecular Dynamics, Sunnyvale, CA. The rabbit polyclonal antibody against rat HO-1 was obtained from StressGen, Victoria, BC. The chemiluminescence detection kit was supplied by New Life Science Products, Boston, MA. The BCA protein assay kit was purchased from Pierce Chemical Co., Rockford, IL. The spectrophotometric device (Spectronic Genesys 5) was obtained from Milton Roy, Ivyland, PA.
Results

Expression of Recombinant HO-1 Adenovirus in the BA
The BAs that were removed 1 day after injection of Ad5HO-1 into the cisterna magna contained increased amounts of HO-1 mRNA (Fig. 1) , whereas injection of Ad-␤Gal or vehicle (10% glycerol in saline) did not result in substantial expression of HO-1 mRNA (three rats per group). There was a statistically nonsignificant increase in expression of HO-1 mRNA in the BAs of rats injected with Ad-␤Gal that was significantly less than in the BAs of rats injected with Ad5HO-1 (p Ͻ 0.001, ANOVA). Significantly increased HO-1 protein, as determined on immunoblot analysis, also was observed in the BA 1 day after intracisternal injection of Ad5HO-1 (three rats per group, p Ͻ 0.001 compared with other groups; ANOVA, Fig. 2 ). Injection of Ad-␤Gal resulted in a low level of expression of HO-1 protein in the BA, whereas injection of vehicle did not.
Immunohistochemical studies of BAs obtained 1 day after injection of Ad5HO-1, Ad-␤Gal, or vehicle showed negligible HO-1 immunoreactivity after injection of vehicle (three rats per group, Fig. 3 ). Marked HO-1 immunoreactivity was detected in the rat BA 1 day after Ad5HO-1 injection. Immunoreactivity was confined to numerous cells in the adventitia and to inflammatory cells that had surrounded the BA and that were not seen after injection of vehicle or around normal BAs. There was no detectable staining in the smooth-muscle cells of the tunica media or in the tunica intima. Occasional cells showing immunoreactivity for HO-1 were observed in the adventitia of BAs of rats injected with Ad-␤Gal, although these cells were much less abundant than after injection of Ad5HO-1. Inflammatory cells containing HO-1 immunoreactivity also were seen around the BA of rats injected with Ad-␤Gal. There was no qualitative difference in the amount of inflammation observed after injection of Ad5HO-1 or Ad-␤Gal. There is significantly more HO-1 protein after injection of Ad5HO-1 compared with groups injected with Ad-␤Gal or vehicle, and also significantly more after injection of Ad-␤Gal compared with vehicle, but it was less than with Ad5HO-1 injections (*p Ͻ 0.001 according to ANOVA).
Effect of HO-1 Transfection on BA Diameter and CBF
The baseline diameter of the BA and its diameter after exposure to increasing doses of ferrous hemoglobin were examined 1 day after intracisternal injection of Ad5HO-1 (10 10 pfu, five rats), Ad-␤Gal (10 10 pfu, five rats), or an equivalent volume of vehicle (six rats). Physiological parameters were maintained within the normal range ( Table  1 ). The diameter of the BA at baseline was significantly greater in the Ad5HO-1 (423 Ϯ 17 m) and Ad-␤Gal (419 Ϯ 13 m) groups compared with vehicle (367 Ϯ 11 m, p Ͻ 0.001, ANOVA, Fig. 4) , although there was no significant difference in diameter between the Ad5HO-1 and Ad-␤Gal groups. Application of 10 Ϫ7 to 10 Ϫ4 mol/L of pure hemoglobin led to contractions that started within minutes and that reached a maximum in 10 minutes. Washout of the hemoglobin with PBS reversed the contraction to baseline diameter in 50 minutes. Hemoglobin caused a concentration-dependent contraction of the BA in each group. To allow for differences in the baseline diameter between groups, the contractions to hemoglobin were expressed as a percentage of the baseline diameter. This did not change the overall pattern, however, which was that contractions of arteries from animals transfected with Ad5HO-1 were always less. The maximal percentage of contraction (Fig. 4) was significantly less (p Ͻ 0.05, ANOVA) in the group injected with Ad5HO-1 compared with Ad-␤Gal.
For LDF-measured blood flow, the baseline CBF and that recorded after application of 10 Ϫ7 to 10 Ϫ4 mol/L hemoglobin were significantly higher in both groups injected with virus than in vehicle-injected control animals (p Ͻ 0.001, ANOVA; Fig. 5 ). For 10 Ϫ4 mol/L hemoglobin, the CBF was significantly higher in the Ad5HO-1 group compared with the other groups (p Ͻ 0.001, ANOVA).
Activity of HO and Carboxyhemoglobin Formation
To determine whether adenovirus-mediated HO-1 transfection produces active HO protein and CO, we examined HO activity and the carboxyhemoglobin concentration in untreated control rats (four for each factor) and in rats 1 day after injection of Ad5HO-1 (six rats each), Ad-␤Gal (HO activity in six and carboxyhemoglobin in four), or vehicle (HO activity in five and carboxyhemoglobin in three) into the cisterna magna. The HO activity was increased significantly in the Ad5HO-1 group compared with the ve- hicle and untreated control groups (p Ͻ 0.001, ANOVA; Fig. 6 ). The HO activity was also higher in the Ad5HO-1 than in the Ad-␤Gal group, although this was significant only according to the unpaired t-test (p Ͻ 0.05). Similarly, for carboxyhemoglobin, there was significant variance, with Ad5HO-1 treatment associated with significantly higher concentrations than in the vehicle or untreated control groups (p Ͻ 0.001, ANOVA) and significantly higher concentrations than in the Ad-␤Gal-injected group according to the unpaired t-test (p Ͻ 0.05, Fig. 6 ).
Effect of Ad5HO-1 on Vasospasm After SAH
Five of 24 rats died of respiratory arrest after the first or second cisternal blood injection. The 19 surviving rats (Ad5HO-1, six rats; Ad-␤Gal, six rats; vehicle, seven rats) exhibited normal behavior and appetite after recovery from SAH and anesthesia. Two additional rats, both in the vehicle group, were killed before Day 7 because of dehydration, anorexia, or severe decrease in activity. Expression of HO-1 mRNA in the Ad5HO-1-injected group increased significantly 7 days after SAH compared with Ad-␤Gal-or vehicle-injected groups (Fig. 7) . Immunoblotting showed that expression of HO-1 protein was significantly greater in the Ad5HO-1 group compared with the Ad-␤Gal and vehicle groups on Day 7 (p Ͻ 0.05, ANOVA). Although HO-1 mRNA was detected on vehicle-injected rats with SAH, protein was not detected by immunoblotting with methods that detected protein in the virus-injected groups.
Overexpression of HO-1 by cisternal injection of Ad-5HO-1 significantly diminished cerebral vasospasm after SAH (Fig. 8) . The diameter of the BA 7 days after SAH was significantly greater after injection of Ad5HO-1 (380 Ϯ 36 m) compared with Ad-␤Gal (282 Ϯ 44 m) and vehicle (287 Ϯ 31 m, p Ͻ 0.001; ANOVA).
Discussion
The new findings in this experiment are that rat BA diameter and CBF can be increased by transfection of cells in the adventitia with adenovirus expressing HO-1 or ␤-galactosidase. Overexpression of the HO-1 protein in the BA of rats specifically increases HO activity, diminishes contractions of the artery to hemoglobin, prevents the reduction in blood flow that occurs after exposure to hemoglobin, and decreases vasospasm after SAH.
Previous investigations have shown that injection of replication-defective adenoviruses expressing ␤-galactosidase, 9 ,41 NOS, 7, 8, 51 or calcitonin gene-related peptide 50 into the cisterna magna can be used to transfect cells in the adventitia and arachnoid membrane of dogs, rats, and mice. The finding that injection of virus mixed with blood does not appreciably alter the pattern of expression is consistent with our results. 35, 40, 46 Injection of NOS and calcitonin generelated peptide were associated with alteration of vascular function when the arteries were removed and studied under isometric tension in vitro. 7, 8, 50, 51 In most of these studies vascular function, arterial diameters at baseline, or CBF in vivo were not assessed.
We previously reported that injection of adenovirus expressing endothelial NOS increased the baseline BA diameter in dogs; 46 arterial diameter was assessed 7 days after viral injection. In the present study we have shown that injection of both control adenovirus expressing ␤-galactosidase and of Ad5HO-1 increased BA diameter and brainstem CBF 1 day later. This may be because injection of virus was associated with acute inflammation, which is known to increase CBF acutely. 15, 21 The increase in CBF may be due to expression of inducible NOS in inflammatory cells, with vasodilation due to the production of nitric oxide. 16 The finding that inhibition of post-SAH inflammation by intracisternal administration of antisense oligonu-
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Prevention of vasospasm with HO-1 gene therapy 1099 FIG. 6. Bar graphs showing HO activity (A) and carboxyhemoglobin (CO-hemoglobin) concentration (B) in rats that 1 day earlier had received intracisternal injections of Ad5HO-1 (six rats), Ad-␤Gal (HO activity, six rats; carboxyhemoglobin, four rats), or vehicle (HO activity, five rats; carboxyhemoglobin, three rats), or untreated control rats (HO activity and carboxyhemoglobin, four rats each). The HO activity was increased significantly in the Ad5HO-1 group compared with the vehicle and untreated control groups (*p Ͻ 0.001 according to ANOVA) and compared with the Ad-␤Gal group (*p Ͻ 0.05 according to the unpaired t-test). Carboxyhemoglobin concentrations showed significant variance, with Ad5HO-1 associated with significantly higher concentrations than vehicle or untreated controls (*p Ͻ 0.001 according to ANOVA), and significantly higher concentrations than Ad-␤Gal, according to the unpaired t-test (p Ͻ 0.05). cleotides to nuclear factor-B prevented vascular contraction 7 days after SAH argues against this mechanism.
36 Another explanation is that both viruses were associated with HO-1 expression and that CO produced by HO-1 led to vasodilation; there is evidence that CO dilates systemic arteries. 18, 23 It has been reported that CO increased CBF in rats, 22 although this phenomenon also could be due to the reduced O 2 -carrying capacity of carboxyhemoglobin. Brian, et al., 4 reported that CO did not dilate cerebral arteries, but this finding is at variance with the accepted opinion that CO is a vasodilator. It is unlikely that HO-1 expression was a nonspecific response to the inflammation in the Ad5HO-1 group, because the virus is known to produce HO-1 in rats, 42 and there was greater HO-1 expression after injection of this virus than after injection of Ad-␤Gal. It must be acknowledged, however, that we cannot differentiate endogenous HO-1 from HO-1 produced by the virus, because both were of rat origin. On the other hand, HO-1 may suppress inflammation, so it would be expected that nonspecific induction of HO-1 due to inflammation would be less in this group. 6 We observed no differences in the degree of inflammation associated with each virus. In our previous study we did not find dilation of the BA in dogs 7 days after intracisternal injection of Ad-␤Gal. One possibility is that the dilatory effects of inflammation induced by Ad-␤Gal are transient. The CBF is elevated in the acute stages of meningitis, and when inflammation becomes chronic the CBF is reduced. 24 Furthermore, inhibition of inflammation 7 days after SAH reduced vasospasm. 36 The duration of transgene expression also must be taken into account, although it was not investigated fully in this model. Christenson, et al., 9 noted that transgene expression lasted only a few days when it was driven by the CMV promoter. There was increased HO-1 expression 7 days post-SAH, after injection of Ad5HO-1, although this did not appear to be as high as after 1 day.
Production of HO-1 in cells in the adventitia was associated with an increase in diameter of the BA and with an increase in CBF in the adjacent brainstem. The vasodilation could be due to several mechanisms. The CO produced by HO-1 could diffuse from adventitial cells to the smoothmuscle cells to mediate this effect. This also would be consistent with the selective reduction in hemoglobin-induced contraction of the BA and the increase in brainstem CBF that was observed. Expression was achieved only in the arterial adventitia, which is consistent with previous reports on the results of cisternal injection of viruses. [7] [8] [9] 39, 41 We previously reported that hemoglobin mediates vasospasm; 27 numerous mechanisms have been proposed, but most involve the intact hemoglobin molecule. 12, 26 Thus, a method for removing hemoglobin more rapidly from the subarachnoid space after SAH might be efficacious in preventing vasospasm. These experiments show that overexpression of HO-1 can reduce the contractile effect of hemoglobin. Numerous mechanisms are possible: overproduction of CO could mediate vascular relaxation or could bind to hemoglobin, preventing hemoglobin from scavenging nitric oxide. The HO could metabolize hemoglobin, producing more CO, which would have the same effects, and reducing the amount of vasoactive hemoglobin. It has been shown previously that induction of HO-1 may mediate similar effects in the systemic vasculature. Infusion of hemoglobin in rats usually elevates blood pressure although this does not occur 1 day after animals are stressed and at a time when HO-1 is induced in the vasculature. 34 Induction of HO-1 is often associated with increased expression of ferritin.
1-3, 6 We did not assess ferritin levels but iron uptake by ferritin could theoretically be involved in preventing hemoglobin-related contraction, because iron compounds may contract cerebral arteries. 13 Iron chelators prevent experimental vasospasm but it seems unlikely that iron released from hemoglobin would participate in its acute contractile action. 17, 52 After observing reduced contractions to hemoglobin, we tested whether Ad5HO-1 could prevent vasospasm after SAH. The rat model of SAH was chosen, which has the benefits of simplicity, economy, and production of a delayed arterial narrowing that lasts for up to 7 days. Two injections of blood were administered, because it is widely accepted that just one injection produces vasospasm that lasts for only 2 days and that is not associated with other accepted features of vasospasm, such as pathological changes in the cerebral arteries. 32 Overexpression of HO-1 reduced vasospasm after SAH. In addition to the mechanisms discussed earlier, HO metabolism of heme produces biliverdin, which could be converted to bilirubin. The importance of this compound in vasospasm is uncertain because it has been reported to cause vasospasm, 11, 27 but it also is an antioxidant that could reduce oxidative reactions that are suggested to mediate vasospasm. 10, 25, 28 Our finding that overexpression of HO-1 reduces vasospasm is consistent with earlier reports of a role for HO-1 in vasospasm.
We have reported that HO-1 and ferritin are increased in monkey cerebral arteries 7 and 14 days after SAH, at a time when vasospasm is resolving even in the continued presence of SAH, indicating that there may be an adaptive response of the cerebral arteries that allows them to relax in the continued presence of the subarachnoid blood that caused the spasm in the first place. 45 Suzuki, et al., 48 showed that HO-1 was markedly overexpressed in the rat BA after SAH and that inhibition of HO-1 expression increased va-sospasm and delayed clearance of hemoglobin from the subarachnoid space after SAH. Theoretically, an additional beneficial effect is that HO may be neuroprotective in cerebral ischemia which is the mechanism by which vasospasm would damage the brain. 10, 19, 49 We could not assess neurological effects of vasospasm in this model because ischemia is not produced.
Conclusions
We report successful transfection of the arterial adventitia of the rat BA with HO-1. Although adenoviral transfection is associated with a nonspecific increase in vascular diameter and CBF after 1 day, HO-1 overexpression specifically prevents hemoglobin-induced contraction of the BA and vasospasm after SAH in a rat double-hemorrhage model. Further investigations are needed to determine the mechanisms of these effects and whether vasospasm can be prevented in models of this disease in large animals.
